These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38543787)

  • 1. CRISPR RNA-Guided Transposases Facilitate Dispensable Gene Study in Phage.
    Liu Y; Liang Z; Yu S; Ye Y; Lin Z
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh.
    Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM
    Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair.
    Wu X; Zhu J; Tao P; Rao VB
    mBio; 2021 Jun; 12(3):e0136121. PubMed ID: 34154416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.
    Pawluk A; Bondy-Denomy J; Cheung VH; Maxwell KL; Davidson AR
    mBio; 2014 Apr; 5(2):e00896. PubMed ID: 24736222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 8. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
    Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
    Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa.
    Carballo-Ontiveros MA; Cazares A; Vinuesa P; Kameyama L; Guarneros G
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.
    Box AM; McGuffie MJ; O'Hara BJ; Seed KD
    J Bacteriol; 2016 Feb; 198(3):578-90. PubMed ID: 26598368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.
    Bondy-Denomy J; Pawluk A; Maxwell KL; Davidson AR
    Nature; 2013 Jan; 493(7432):429-32. PubMed ID: 23242138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Genome Editing of Virulent Pseudomonas Phages Using CRISPR-Cas3.
    Schroven K; Voet M; Lavigne R; Hendrix H
    Methods Mol Biol; 2024; 2793():113-128. PubMed ID: 38526727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage genome engineering with CRISPR-Cas13a.
    Guan J; Oromí-Bosch A; Mendoza SD; Karambelkar S; Berry JD; Bondy-Denomy J
    Nat Microbiol; 2022 Dec; 7(12):1956-1966. PubMed ID: 36316452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of temperate phages drives loss of type I CRISPR-Cas systems.
    Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER
    Nature; 2020 Feb; 578(7793):149-153. PubMed ID: 31969710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial alginate regulators and phage homologs repress CRISPR-Cas immunity.
    Borges AL; Castro B; Govindarajan S; Solvik T; Escalante V; Bondy-Denomy J
    Nat Microbiol; 2020 May; 5(5):679-687. PubMed ID: 32203410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
    Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of CRISPR-Cas systems by Tn7-like transposons.
    Peters JE; Makarova KS; Shmakov S; Koonin EV
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7358-E7366. PubMed ID: 28811374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the molecular mechanism of the transposon-encoded type I-F CRISPR-Cas system.
    Alalmaie A; Diaf S; Khashan R
    J Genet Eng Biotechnol; 2023 May; 21(1):60. PubMed ID: 37191877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.